Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Carcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Diseases 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Disease 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Merkel Cell 1Brain Neoplasms 1Astrocytoma 1

Interventions

Tomography, X-Ray Computed 2Hematologic Tests 2Blood Specimen Collection 2tivozanib 1pembrolizumab 1aflibercept 1Videotape Recording 1Urination 1Thoracoscopy 1Thoracic Surgical Procedures 1Sulfonylurea Compounds 1Sodium-Glucose Transporter 2 Inhibitors 1Referral and Consultation 1Octreotide 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Ipilimumab 1Interviews as Topic 1Interleukin-15 1In Situ Hybridization 1Immunohistochemistry 1Exercise 1Erlotinib Hydrochloride 1Equipment and Supplies 1Educational Status 1Dipeptidyl-Peptidase IV Inhibitors 1Diagnostic Tests, Routine 1Diagnosis 1Clinical Laboratory Techniques 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × aflibercept × Thoracic × Clear all
NCT00284141 2012-12-10

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Sanofi

Phase 2 Completed
98 enrolled 14 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Disease, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡